Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018.
Rudnick W, Conly J, Thirion DJG, Choi K, Pelude L, Cayen J, Bautista J, Beique L, Comeau JL, Dalton B, Delport J, Dhami R, Embree J, Émond Y, Evans G, Frenette C, Fryters S, Happe J, Katz K, Kibsey P, Langley JM, Lee BE, Lefebvre MA, Leis JA, McGeer A, McKenna S, Neville HL, Slayter K, Suh KN, Tse-Chang A, Weiss K, Science M; Canadian Nosocomial Infection Surveillance Program. Rudnick W, et al. Among authors: langley jm. Antimicrob Resist Infect Control. 2023 Apr 18;12(1):35. doi: 10.1186/s13756-023-01219-x. Antimicrob Resist Infect Control. 2023. PMID: 37072874 Free PMC article.
The responsiveness and validity of the CAMPHOR Utility Index.
Meads DM, McKenna SP, Doughty N, Das C, Gin-Sing W, Langley J, Pepke-Zaba J. Meads DM, et al. Eur Respir J. 2008 Dec;32(6):1513-9. doi: 10.1183/09031936.00069708. Epub 2008 Sep 3. Eur Respir J. 2008. PMID: 18768576 Free article.
Efficacy and safety of respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons.
Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Verheust C, Dezutter N, Gruselle O, Fissette L, David MP, Kostanyan L, Hulstrøm V, Olivier A, Van der Wielen M, Descamps D; AReSVi-006 study group. Ison MG, et al. Among authors: langley jm. Clin Infect Dis. 2024 Jan 22:ciae010. doi: 10.1093/cid/ciae010. Online ahead of print. Clin Infect Dis. 2024. PMID: 38253338
Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM. Shoukat A, et al. Among authors: langley jm. Lancet Reg Health Am. 2023 Nov 9;28:100629. doi: 10.1016/j.lana.2023.100629. eCollection 2023 Dec. Lancet Reg Health Am. 2023. PMID: 38026446 Free PMC article.
PreHevbrio: the first approved 3-antigen hepatitis B vaccine.
Vesikari T, Langley JM, Popovic V, Diaz-Mitoma F. Vesikari T, et al. Among authors: langley jm. Expert Rev Vaccines. 2023 Jan-Dec;22(1):1041-1054. doi: 10.1080/14760584.2023.2274482. Epub 2023 Nov 6. Expert Rev Vaccines. 2023. PMID: 37877189 Free article. Review.
Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 Pandemic.
Bourdeau M, Vadlamudi NK, Bastien N, Embree J, Halperin SA, Jadavji T, Kazmi K, Langley JM, Lebel MH, Le Saux N, Moore D, Morris SK, Pernica JM, Robinson J, Sadarangani M, Bettinger JA, Papenburg J; Canadian Immunization Monitoring Program Active (IMPACT) Investigators. Bourdeau M, et al. Among authors: langley jm. JAMA Netw Open. 2023 Oct 2;6(10):e2336863. doi: 10.1001/jamanetworkopen.2023.36863. JAMA Netw Open. 2023. PMID: 37792376 Free PMC article.
245 results